Gorbet, M., & Ranjan, A. (2019). Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacol Ther.
Chicago Style CitationGorbet, Michael-Joseph, i Ashish Ranjan. "Cancer Immunotherapy With Immunoadjuvants, Nanoparticles, and Checkpoint Inhibitors: Recent Progress and Challenges in Treatment and Tracking Response to Immunotherapy." Pharmacol Ther 2019.
Cita MLAGorbet, Michael-Joseph, i Ashish Ranjan. "Cancer Immunotherapy With Immunoadjuvants, Nanoparticles, and Checkpoint Inhibitors: Recent Progress and Challenges in Treatment and Tracking Response to Immunotherapy." Pharmacol Ther 2019.
Atenció: Aquestes cites poden no estar 100% correctes.